Gavi, the Vaccine Alliance has signed advance purchase agreements (APAs) for a total of up to 550 million doses of Covid-19 vaccines from Sinopharm and Sinovac for supply through the COVAX facility.
Fusion Pharmaceuticals Inc. has entered into an asset purchase agreement (APA) to acquire Ipsen's intellectual property and assets related to IPN-1087.